32 research outputs found
Percutaneous coronary intervention in Europe 1992-2003
peer reviewedAims: The purpose of this registry is to collect data on trends in interventional cardiology within Europe.
Special interest focuses on relative increases and ratios in newer revascularization approaches and its distribution
in different regions in Europe. We report the data of the year 2003 and give an overview of the
development of coronary interventions since 1992, when the first data collection was performed.
Methods and results: Questionnaires were distributed yearly to delegates of all national societies of cardiology
represented in the European Society of Cardiology to collect the case numbers of all local institutions
and operators. The overall numbers of coronary angiographies increased from 1992 to 2003 from 684,000
to 1,993,000 (from 1,250 to 3,500 per million inhabitants). The respective numbers for percutaneous
coronary interventions (PCI-coronary angioplasty) and coronary stenting procedures increased from
184,000 to 733,000 (from 335 to 1,300) and from 3,000 to 610,000 (from 5 to 1,100), respectively.
Germany has been the most active country for the past years with 653,000 angiographies (7,800),
222,000 angioplasties (2,500), and 180,000 stenting procedures (2,200) in 2003. The indication has shifted
towards acute coronary syndromes, as demonstrated by raising rates of interventions for acute myocardial
infarction over the last decade. The procedures are more readily performed and safer, as shown by
increasing rate of âad hocâ PCI and decreasing need for emergency coronary artery bypass surgery
(CABG). In 2003, use of drug-eluting stents had further increased. However, an enormous variability is
reported with the highest rate in Portugal (55%).
Conclusion: Interventional cardiology in Europe is still expanding, mainly but not exclusively due to rapid
growth in the eastern European countries. A number of new coronary revascularization procedures introduced
over the years have all but disappeared. Only stenting has experienced an exponential growth. The
same can be forecast for drug-eluting stenting
Right ventricle to pulmonary artery coupling after transcatheter aortic valve implantationâDeterminant factors and prognostic impact
IntroductionRight ventricular (RV) dysfunction and pulmonary hypertension (PH) have been previously associated with unfavorable outcomes in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI), but little is known about the effect of right ventricle (RV) to pulmonary artery (PA) coupling. Our study aimed to evaluate the determinant factors and the prognostic value of RV-PA coupling in patients undergoing TAVI.MethodsOne hundred sixty consecutive patients with severe AS were prospectively enrolled, between September 2018 and May 2020. They underwent a comprehensive echocardiogram before and 30 days after TAVI, including speckle tracking echocardiography (STE) for myocardial deformation analysis of the left ventricle (LV), left atrium (LA), and RV function. Complete data on myocardial deformation was available in 132 patients (76.6â±â7.5 years, 52.5% men) who formed the final study population. The ratio of RV free wall longitudinal strain (RV-FWLS) to PA systolic pressure (PASP) was used as an estimate of RV-PA coupling. Patients were analyzed according to baseline RV-FWLS/PASP cut-off point, determined through time-dependent ROC curve analysis, as follows: normal RV-PA coupling group (RV-FWLS/PASP â„0.63, nâ=â65) and impaired RV-PA coupling group (RV-FWLS/PASPâ<â0.63, nâ=â67).ResultsA significant improvement of RV-PA coupling was observed early after TAVI (0.75â±â0.3 vs. 0.64â±â0.3 before TAVI, pâ<â0.001), mainly due to PASP decrease (pâ<â0.001). LA global longitudinal strain (LA-GLS) is an independent predictor of RV-PA coupling impairment before and after TAVI (ORâ=â0.837, pâ<â0.001, ORâ=â0.848, pâ<â0.001, respectively), while RV diameter is an independent predictor of persistent RV-PA coupling impairment after TAVI (ORâ=â1.174, pâ=â0.002). Impaired RV-PA coupling was associated with a worse survival rate (66.3% vs. 94.9%, p-valueâ<â0.001) and emerged as an independent predictor of mortality (HRâ=â5.97, CIâ=â1.44â24.8, pâ=â0.014) and of the composite endpoint of death and rehospitalization (HRâ=â4.14, CIâ=â1.37â12.5, pâ=â0.012).ConclusionOur results confirm that relief of aortic valve obstruction has beneficial effects on the baseline RV-PA coupling, and they occur early after TAVI. Despite significant improvement in LV, LA, and RV function after TAVI, RV-PA coupling remains impaired in some patients, it is mainly related to persistent pulmonary hypertension and is associated with adverse outcomes
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encourage
Occult fractures of the proximal femur: imaging diagnosis and management of 82 cases in a regional trauma center
What did we learn from a large cohort of more than 24,000 patients evaluated by transient elastography in a single-center?
Isolated coronary artery ectasia presenting as inferior-posterior STEMIâa case-based state-of-the-art review of the current literature
This review is based on the case of a 71-year-old female patient, with cardiovascular risk factors, who was referred for emergency cardiological evaluation after experiencing severe anterior chest pain that had lasted for more than 5 hours at the time of admission